Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.

Xie Y, Bowe B, Yan Y, Xian H, Li T, Al-Aly Z.

BMJ. 2019 May 29;365:l1580. doi: 10.1136/bmj.l1580.

2.

Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution.

Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z.

BMJ Open. 2019 May 9;9(5):e022450. doi: 10.1136/bmjopen-2018-022450.

3.

Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.

Bowe B, Xie Y, Li T, Mokdad AH, Xian H, Yan Y, Maddukuri G, Al-Aly Z.

JAMA Netw Open. 2018 Nov 2;1(7):e184412. doi: 10.1001/jamanetworkopen.2018.4412.

4.

Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.

Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai CY, Floyd T, Al-Aly Z.

Kidney Int. 2018 Sep;94(3):567-581. doi: 10.1016/j.kint.2018.04.011. Epub 2018 Aug 3.

5.

The 2016 global and national burden of diabetes mellitus attributable to PM2·5 air pollution.

Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z.

Lancet Planet Health. 2018 Jul;2(7):e301-e312. doi: 10.1016/S2542-5196(18)30140-2.

6.

Monocyte count modifies the association between chronic kidney disease and risk of death
.

Koraishy FM, Bowe B, Xie Y, Xian H, Al-Aly Z.

Clin Nephrol. 2018 Sep;90(3):194-208. doi: 10.5414/CN109434.

PMID:
29974856
7.

Blood urea nitrogen and risk of insulin use among people with diabetes.

Xie Y, Bowe B, Li T, Xian H, Al-Aly Z.

Diab Vasc Dis Res. 2018 Sep;15(5):409-416. doi: 10.1177/1479164118785050. Epub 2018 Jul 5.

PMID:
29974791
8.

Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: a cohort study.

Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z.

Lancet Planet Health. 2017 Oct;1(7):e267-e276. doi: 10.1016/S2542-5196(17)30117-1. Epub 2017 Oct 5.

9.

The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States.

US Burden of Disease Collaborators, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi A, Ferrari AJ, Kasaeian A, Werdecker A, Carter A, Zipkin B, Sartorius B, Serdar B, Sykes BL, Troeger C, Fitzmaurice C, Rehm CD, Santomauro D, Kim D, Colombara D, Schwebel DC, Tsoi D, Kolte D, Nsoesie E, Nichols E, Oren E, Charlson FJ, Patton GC, Roth GA, Hosgood HD, Whiteford HA, Kyu H, Erskine HE, Huang H, Martopullo I, Singh JA, Nachega JB, Sanabria JR, Abbas K, Ong K, Tabb K, Krohn KJ, Cornaby L, Degenhardt L, Moses M, Farvid M, Griswold M, Criqui M, Bell M, Nguyen M, Wallin M, Mirarefin M, Qorbani M, Younis M, Fullman N, Liu P, Briant P, Gona P, Havmoller R, Leung R, Kimokoti R, Bazargan-Hejazi S, Hay SI, Yadgir S, Biryukov S, Vollset SE, Alam T, Frank T, Farid T, Miller T, Vos T, Bärnighausen T, Gebrehiwot TT, Yano Y, Al-Aly Z, Mehari A, Handal A, Kandel A, Anderson B, Biroscak B, Mozaffarian D, Dorsey ER, Ding EL, Park EK, Wagner G, Hu G, Chen H, Sunshine JE, Khubchandani J, Leasher J, Leung J, Salomon J, Unutzer J, Cahill L, Cooper L, Horino M, Brauer M, Breitborde N, Hotez P, Topor-Madry R, Soneji S, Stranges S, James S, Amrock S, Jayaraman S, Patel T, Akinyemiju T, Skirbekk V, Kinfu Y, Bhutta Z, Jonas JB, Murray CJL.

JAMA. 2018 Apr 10;319(14):1444-1472. doi: 10.1001/jama.2018.0158.

10.

The association of proton pump inhibitors and chronic kidney disease: cause or confounding?

Li T, Xie Y, Al-Aly Z.

Curr Opin Nephrol Hypertens. 2018 May;27(3):182-187. doi: 10.1097/MNH.0000000000000406. Review.

PMID:
29432214
11.

A big data approach to examine the association of high density lipoprotein cholesterol and mortality: lessons for future investigations.

Al-Aly Z.

J Thorac Dis. 2017 Dec;9(12):4926-4928. doi: 10.21037/jtd.2017.11.95. No abstract available.

12.

Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus.

Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z.

Kidney Int. 2018 Mar;93(3):741-752. doi: 10.1016/j.kint.2017.08.033. Epub 2017 Dec 11.

13.

Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD.

Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z.

J Am Soc Nephrol. 2018 Jan;29(1):218-230. doi: 10.1681/ASN.2017030253. Epub 2017 Sep 21.

14.

Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.

Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z.

BMJ Open. 2017 Jul 4;7(6):e015735. doi: 10.1136/bmjopen-2016-015735.

15.

Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, Salama JS, Vos T, Abate KH, Abbafati C, Ahmed MB, Al-Aly Z, Alkerwi A, Al-Raddadi R, Amare AT, Amberbir A, Amegah AK, Amini E, Amrock SM, Anjana RM, Ärnlöv J, Asayesh H, Banerjee A, Barac A, Baye E, Bennett DA, Beyene AS, Biadgilign S, Biryukov S, Bjertness E, Boneya DJ, Campos-Nonato I, Carrero JJ, Cecilio P, Cercy K, Ciobanu LG, Cornaby L, Damtew SA, Dandona L, Dandona R, Dharmaratne SD, Duncan BB, Eshrati B, Esteghamati A, Feigin VL, Fernandes JC, Fürst T, Gebrehiwot TT, Gold A, Gona PN, Goto A, Habtewold TD, Hadush KT, Hafezi-Nejad N, Hay SI, Horino M, Islami F, Kamal R, Kasaeian A, Katikireddi SV, Kengne AP, Kesavachandran CN, Khader YS, Khang YH, Khubchandani J, Kim D, Kim YJ, Kinfu Y, Kosen S, Ku T, Defo BK, Kumar GA, Larson HJ, Leinsalu M, Liang X, Lim SS, Liu P, Lopez AD, Lozano R, Majeed A, Malekzadeh R, Malta DC, Mazidi M, McAlinden C, McGarvey ST, Mengistu DT, Mensah GA, Mensink GBM, Mezgebe HB, Mirrakhimov EM, Mueller UO, Noubiap JJ, Obermeyer CM, Ogbo FA, Owolabi MO, Patton GC, Pourmalek F, Qorbani M, Rafay A, Rai RK, Ranabhat CL, Reinig N, Safiri S, Salomon JA, Sanabria JR, Santos IS, Sartorius B, Sawhney M, Schmidhuber J, Schutte AE, Schmidt MI, Sepanlou SG, Shamsizadeh M, Sheikhbahaei S, Shin MJ, Shiri R, Shiue I, Roba HS, Silva DAS, Silverberg JI, Singh JA, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tegegne BS, Terkawi AS, Thakur JS, Tonelli M, Topor-Madry R, Tyrovolas S, Ukwaja KN, Uthman OA, Vaezghasemi M, Vasankari T, Vlassov VV, Vollset SE, Weiderpass E, Werdecker A, Wesana J, Westerman R, Yano Y, Yonemoto N, Yonga G, Zaidi Z, Zenebe ZM, Zipkin B, Murray CJL.

N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.

16.

Global Cardiovascular and Renal Outcomes of Reduced GFR.

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero JJ, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort RT, Gona PN, Gutierrez OM, Hamidi S, Hanson SW, Himmelfarb J, Jassal SK, Jee SH, Jha V, Jimenez-Corona A, Jonas JB, Kengne AP, Khader Y, Khang YH, Kim YJ, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey AS, Li Y, Lotufo P, El Razek HMA, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner PM, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum KU, Sawhney M, Schöttker B, Shankar A, Shlipak M, Silva DAS, Toyoshima H, Ukwaja K, Umesawa M, Vollset SE, Warnock DG, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki MES, Naghavi M, Forouzanfar MH, Murray CJL, Coresh J, Vos T; Global Burden of Disease 2013 GFR Collaborators; CKD Prognosis Consortium; Global Burden of Disease Genitourinary Expert Group.

J Am Soc Nephrol. 2017 Jul;28(7):2167-2179. doi: 10.1681/ASN.2016050562. Epub 2017 Apr 13.

17.

Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.

Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):603-613. doi: 10.2215/CJN.09710916. Epub 2017 Mar 27.

18.

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.

Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z.

Kidney Int. 2017 Jun;91(6):1482-1494. doi: 10.1016/j.kint.2016.12.021. Epub 2017 Feb 22.

19.

Serum phosphorus levels and risk of incident dementia.

Li T, Xie Y, Bowe B, Xian H, Al-Aly Z.

PLoS One. 2017 Feb 2;12(2):e0171377. doi: 10.1371/journal.pone.0171377. eCollection 2017.

20.

High density lipoprotein cholesterol and risk of death.

Al-Aly Z.

J Thorac Dis. 2016 Dec;8(12):E1780-E1781. doi: 10.21037/jtd.2016.12.65. No abstract available.

21.

Geographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline.

Bowe B, Xie Y, Xian H, Lian M, Al-Aly Z.

Kidney Int Rep. 2016 Aug 30;2(1):5-17. doi: 10.1016/j.ekir.2016.08.016. eCollection 2017 Jan.

22.

High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed MA, Al-Aly Z.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1784-1793. doi: 10.2215/CJN.00730116. Epub 2016 Aug 11.

23.

Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z.

J Am Soc Nephrol. 2016 Oct;27(10):3153-3163. Epub 2016 Apr 14.

24.

Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.

Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z.

Am J Kidney Dis. 2016 Aug;68(2):219-228. doi: 10.1053/j.ajkd.2016.02.039. Epub 2016 Mar 4.

PMID:
26948835
25.

Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.

Bowe B, Xie Y, Xian H, Balasubramanian S, Al-Aly Z.

Kidney Int. 2016 Apr;89(4):886-96. doi: 10.1016/j.kint.2015.12.034. Epub 2016 Jan 29.

PMID:
26924057
26.

Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death.

Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z.

PLoS One. 2016 Feb 22;11(2):e0149283. doi: 10.1371/journal.pone.0149283. eCollection 2016.

27.

Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD.

Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1946-55. doi: 10.2215/CJN.04480415. Epub 2015 Sep 8.

28.

Acute kidney injury after cardiac surgery: is minocycline protective?

Golestaneh L, Lindsey K, Malhotra P, Kargoli F, Farkas E, Barner H, Qazi R, Schmidt A, Rauchman M, Al-Aly Z, Johnson R, Martin K, Dagher P, Friedman A, El-Achkar TM.

J Nephrol. 2015 Apr;28(2):193-9. doi: 10.1007/s40620-014-0152-2. Epub 2014 Oct 28.

PMID:
25348221
29.

Prediction of renal end points in chronic kidney disease.

Al-Aly Z.

Kidney Int. 2013 Feb;83(2):189-91. doi: 10.1038/ki.2012.418.

30.

Greater variability in kidney function is associated with an increased risk of death.

Al-Aly Z, Balasubramanian S, McDonald JR, Scherrer JF, O'Hare AM.

Kidney Int. 2012 Dec;82(11):1208-14. doi: 10.1038/ki.2012.276. Epub 2012 Aug 1.

31.

Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.

Nurutdinova D, Chrusciel T, Zeringue A, Scherrer JF, Al-Aly Z, McDonald JR, Overton ET.

AIDS. 2012 Jan 14;26(2):229-34. doi: 10.1097/QAD.0b013e32834e1404.

PMID:
22089375
32.

Rate of change in kidney function and the risk of death: the case for incorporating the rate of kidney function decline into the CKD staging system.

Al-Aly Z, Cepeda O.

Nephron Clin Pract. 2011;119(2):c179-85; discussion c186. doi: 10.1159/000324768. Epub 2011 Jul 28. Review.

33.

Phosphate, oxidative stress, and nuclear factor-κB activation in vascular calcification.

Al-Aly Z.

Kidney Int. 2011 May;79(10):1044-7. doi: 10.1038/ki.2010.548.

34.

Tamm-Horsfall protein-deficient thick ascending limbs promote injury to neighboring S3 segments in an MIP-2-dependent mechanism.

El-Achkar TM, McCracken R, Rauchman M, Heitmeier MR, Al-Aly Z, Dagher PC, Wu XR.

Am J Physiol Renal Physiol. 2011 Apr;300(4):F999-1007. doi: 10.1152/ajprenal.00621.2010. Epub 2011 Jan 12.

35.

Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study.

Balasubramanian G, Al-Aly Z, Moiz A, Rauchman M, Zhang Z, Gopalakrishnan R, Balasubramanian S, El-Achkar TM.

Am J Kidney Dis. 2011 Feb;57(2):228-34. doi: 10.1053/j.ajkd.2010.08.026. Epub 2010 Dec 31.

PMID:
21195518
36.

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.

Al-Aly Z, Pan H, Zeringue A, Xian H, McDonald JR, El-Achkar TM, Eisen S.

Transl Res. 2011 Jan;157(1):10-8. doi: 10.1016/j.trsl.2010.09.005. Epub 2010 Oct 21.

PMID:
21146146
37.

Rate of kidney function decline associates with mortality.

Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S.

J Am Soc Nephrol. 2010 Nov;21(11):1961-9. doi: 10.1681/ASN.2009121210. Epub 2010 Oct 14.

38.

The new role of calcimimetics as vasculotropic agents.

Al-Aly Z.

Kidney Int. 2009 Jan;75(1):9-12. doi: 10.1038/ki.2008.563. Review.

39.

Vascular calcification in uremia: what is new and where are we going?

Al-Aly Z.

Adv Chronic Kidney Dis. 2008 Oct;15(4):413-9. doi: 10.1053/j.ackd.2008.07.011. Review.

PMID:
18805387
40.

Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy.

Al-Aly Z.

Transl Res. 2008 May;151(5):233-9. doi: 10.1016/j.trsl.2007.12.005. Epub 2008 Jan 22. Review.

PMID:
18433704
41.
42.

Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system.

Al-Aly Z, Reddivari V, Moiz A, Balasubramanian G, Cortese CM, Salinas-Madrigal L, Bastani B.

Transpl Int. 2008 Mar;21(3):268-75. Epub 2007 Dec 5.

43.

Evaluation of serum anion gap in patients with HIV.

Al-Aly Z, Valdez H, Moiz A, Bastani B.

J Nephrol. 2007 Nov-Dec;20(6):727-30.

PMID:
18046675
44.

Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.

Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, Cheng SL, Towler DA.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2589-96. Epub 2007 Oct 11.

PMID:
17932314
46.

Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.

Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ.

Am J Kidney Dis. 2007 Jul;50(1):59-68.

PMID:
17591525
47.

Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation.

Al-Aly Z.

Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):1-6. Review.

PMID:
17346122
48.
49.

Pasteurella multocida peritoneal dialysis-associated peritonitis: a report of two cases and review of the literature.

Malik A, Al Aly Z, Mailey KS, Bastani B.

J Nephrol. 2005 Nov-Dec;18(6):791-3.

PMID:
16358243
50.

The natural history of renal function following orthotopic heart transplant.

Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.

Clin Transplant. 2005 Oct;19(5):683-9.

PMID:
16146562

Supplemental Content

Loading ...
Support Center